A Positive Research Inc — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$37,335	5
2024	Research	$16,419	3
2023	Research	$36,521	5
2022	Research	$49,656	82
2021	Research	$37,033	86
2020	Research	$9,092	24

Breakdown

Who paid Research payments · program years 2020–2025

Esperion Therapeutics, Inc. $132,302 197 payments
AbbVie, Inc. $50,203 7 payments
Genentech, Inc. $3,551 1 payment

Studies the money was for Research payments · program years 2020–2025

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (Etc-1002) on the Occurrence of Major Cardiovascular Events in Patients With, Or at High Risk For, Cardiovascular Disease Who Are Statin Intolerant $132,302 197 payments
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn s Disease (Target CD) $46,295 5 payments
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn s Disease (Target CD) $3,840 1 payment
Roche Cancer Screening Collection Study $3,551 1 payment
M24-885 ABBV-766 Ph 2 PoC Combo study (066 + 981;323; 382) $68 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.